Page last updated: 2024-11-01

nifedipine and Triple Negative Breast Neoplasms

nifedipine has been researched along with Triple Negative Breast Neoplasms in 1 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.

Research Excerpts

ExcerptRelevanceReference
"One of the most common signs of breast tumors is the presence of small deposits of calcium, known as microcalcifications."1.56Calcium signaling affects migration and proliferation differently in individual cancer cells due to nifedipine treatment. ( Babula, P; Chovancova, B; Durinikova, E; Hudecova, S; Krizanova, O; Liskova, V; Matuskova, M; Miklikova, S; Novakova, M; Penesova, A; Sevcikova, A, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chovancova, B1
Liskova, V1
Miklikova, S1
Hudecova, S1
Babula, P1
Penesova, A1
Sevcikova, A1
Durinikova, E1
Novakova, M1
Matuskova, M1
Krizanova, O1

Other Studies

1 other study available for nifedipine and Triple Negative Breast Neoplasms

ArticleYear
Calcium signaling affects migration and proliferation differently in individual cancer cells due to nifedipine treatment.
    Biochemical pharmacology, 2020, Volume: 171

    Topics: Antineoplastic Agents, Immunological; Apoptosis; Breast Neoplasms; Calcium Channel Blockers; Calcium

2020